Welcome to our dedicated page for Esco Technologies SEC filings (Ticker: ESE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ESCO Technologies Inc. filings document the regulatory record of a NYSE-listed engineered-products company with common stock traded under ESE. Its Form 8-K reports furnish quarterly and annual operating results, Regulation FD disclosures, material-event updates, exhibits, and capital-structure information tied to corporate actions and financing matters.
Proxy materials and shareholder-vote disclosures cover board elections, governance matters, compensation arrangements, equity incentive awards, and annual meeting proposals. The filings also provide formal disclosure around the company’s portfolio structure, including Aerospace & Defense, Utility Solutions Group, and RF Test & Measurement operations, as well as completed acquisition and divestiture activity reflected in its public-company reporting.
ESCO Technologies (ESE) reported third-quarter net sales of $296.3 million, up 26.8% from $233.6 million a year earlier, and nine-month sales of $742.7 million, up 15.0% year-over-year. Quarterly net earnings from continuing operations were $24.8 million versus $28.3 million last year; nine-month earnings from continuing operations rose to $71.4 million from $63.3 million. Diluted EPS from continuing operations was $0.96 for the quarter and $2.76 for the nine months.
The company completed a material acquisition on April 25, 2025, buying Signature Management & Power for approximately $472 million; Maritime contributed $37.1 million of revenue in the quarter and added substantial backlog and intangible assets, generating $222.7 million of goodwill. Backlog from continuing operations grew to $1,165.4 million from $664 million at September 30, 2024. The company also announced and subsequently completed the sale of VACCO, receiving about $275 million in net proceeds; VACCO is reported as discontinued operations.
Liquidity shows $78.7 million cash on hand and available credit under the facility; total borrowings increased to $525 million with long-term debt (net of current portion) of $505 million. Interest expense and the effective tax rate rose, reflecting acquisition-related financing and tax consequences.